JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity. [electronic resource]
- Oncotarget Mar 2017
- 21918-21929 p. digital
Publication Type: Journal Article
1949-2553
10.18632/oncotarget.15747 doi
Animals Apoptosis Biomarkers, Tumor--genetics Bone Density Conservation Agents--pharmacology Breast Neoplasms--drug therapy Cell Proliferation DNA Methylation--drug effects Ergocalciferols--pharmacology Female Gene Expression Regulation, Neoplastic Histone Demethylases--metabolism Humans Jumonji Domain-Containing Histone Demethylases--genetics Mice Mice, Inbred BALB C Mice, Nude Neoplastic Stem Cells--drug effects Octamer Transcription Factor-3--antagonists & inhibitors Tumor Cells, Cultured Xenograft Model Antitumor Assays